Inhibition and kinetics of mycobacterium tuberculosis and Mycobacterium Smegmatis mycothiol-S-conjugate amidase by natural product inhibitors

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 4, 2002, Pages 601-608

  Nicholas, Gillian M ^a,c   Eckman, Lisa L ^a   Newton, Gerald L ^b   Fahey, Robert C ^b   Ray, Satyajit ^a   Bewley, Carole A ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CRO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; BROMOTYROSINE; ENZYME INHIBITOR; GLIOTOXIN; OCEANAPISIDE; PSAMMAPLYSIN A; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG SCREENING; ENZYME ASSAY; ENZYME INHIBITION; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

AMIDOHYDROLASES; ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; ASPERGILLUS; BIOLOGICAL FACTORS; DRUG DESIGN; ENZYME INHIBITORS; FUNGI; KINETICS; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; PORIFERA; STRUCTURE-ACTIVITY RELATIONSHIP;

FUNGI; INVERTEBRATA; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS;

EID: 0037245381     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00345-0     Document Type: Article

References (34)

1. For recent reviews, see: (a) Dye C., Williams B.G., Espinal M.A., Raviglione M.C. Science. 295:2002;2041. Pozniak (b) A. Ann. N.Y. Acad. Sci. 953:2001;952. (c) Grange J.M., Zumla A. Lancet. 353:1999;996.
2. For recent reviews, see: (a) Dye C., Williams B.G., Espinal M.A., Raviglione M.C. Science. 295:2002;2041. Pozniak (b) A. Ann. N.Y. Acad. Sci. 953:2001;952. (c) Grange J.M., Zumla A. Lancet. 353:1999;996.
3. For recent reviews, see: (a) Dye C., Williams B.G., Espinal M.A., Raviglione M.C. Science. 295:2002;2041. Pozniak (b) A. Ann. N.Y. Acad. Sci. 953:2001;952. (c) Grange J.M., Zumla A. Lancet. 353:1999;996.
4. Newton G.L., Av-Gay Y., Fahey R.C. Biochemistry. 39:2000;10739.
5. Sakuda S., Zhou Z., Yamada Y. Biosci. Biotech. Biochem. 58:1994;1347.
6. Spies H.S., Steenkamp D.J. Eur. J. Biochem. 224:1994;203.
7. Newton G.L., Bewley C.A., Dwyer T.J., Horn R., Aharonowitz Y., Cohen G., Davies J., Faulkner D.J., Fahey R.C. Eur. J. Biochem. 230:1995;821.
8. Nicholas G.M., Kováč P., Bewley C.A. J. Am. Chem. Soc. 124:2002;3492.
9. Reviewed in Fahey R.C. Ann. Rev. Microbiol. 55:2001;333.
10. Altschul S.F., Gish W., Miller W., Myers E.W., Lipman D.J. J. Mol. Biol. 215:1990;403.
11. Obtained from the Natural Products Open Repository, National Cancer Institute.
12. Nicholas G.M., Newton G.L., Fahey R.C., Bewley C.A. Org. Lett. 3:2001;1543.
13. Nicholas G.M., Eckman L.L., Ray S., Hughes R.O., Pfefferkorn J., Barluenga S., Nicolaou K.C., Bewley C.A. Bioorg. Med. Chem. Lett. 12:2002;2487.
14. Nicolaou K.C., Hughes R., Pfefferkorn J.A., Barluenga S., Roeker A.J. Chem. Eur. J. 7:2001;4280.
15. Benharref A., Pais M. J. Nat. Prod. 59:1996;177.
16. Roll D.M., Chang C.W.J., Scheuer P.J., Gray G.A., Shoolery J.N., Matsumoto G.K., Van Duyne G.D., Clardy J.C. J. Am. Chem. Soc. 107:1985;2916.
17. Litaudon M., Guyot M. Tetrahedron Lett. 27:1986;4455.
18. Nicholas G.M., Hong T.W., Molinski T.F., Lerch M.L., Cancilla M.T., Lebrilla C.B. J. Nat. Prod. 62:1999;1678.
19. Manes L.V., Crews P., Kernan M.R., Faulkner D.J., Fronczek F.R., Gandour R.D. J. Org. Chem. 53:1988;570.
20. Kernan M.R., Faulker D.J. J. Org. Chem. 53:1988;4574.
21. Davies-Coleman M.T., Faulkner D.J., Dubowchik G.M., Roth G.P., Polson C., Fairchild C. J. Org. Chem. 58:1993;5925.
22. Weindling R. Phytopathology. 31:1941;991.
23. Kirby G.W., Robins D.J., Sefton M.A., Talekar R.R. J. Chem. Soc., Perkin Trans. 1. 1980;119.
24. Reviewed in Anke H., Kolthoum I., Zahner H., Laatsch H. Arch. Microbiol. 126:1980;223.
25. Shindler, J. S.; Bardsley, W. G. Biochem. Pharm. 1976, 25, 2689. Cornish-Bowden, A. In Principles of Enzyme Kinetics; Butterworths: London, 1976. Henderson, P. J. F. In Enzyme Assays, A Practical Approach; Eisenthal, R., Danson, M. J. Eds.; Oxford University Press: New York, 1998; p 277.
26. Shindler, J. S.; Bardsley, W. G. Biochem. Pharm. 1976, 25, 2689. Cornish-Bowden, A. In Principles of Enzyme Kinetics; Butterworths: London, 1976. Henderson, P. J. F. In Enzyme Assays, A Practical Approach; Eisenthal, R., Danson, M. J. Eds.; Oxford University Press: New York, 1998; p 277.
27. Shindler, J. S.; Bardsley, W. G. Biochem. Pharm. 1976, 25, 2689. Cornish-Bowden, A. In Principles of Enzyme Kinetics; Butterworths: London, 1976. Henderson, P. J. F. In Enzyme Assays, A Practical Approach; Eisenthal, R., Danson, M. J. Eds.; Oxford University Press: New York, 1998; p 277.
28. Hamann M.T., Scheuer P.J., Kelly-Borges M. J. Org. Chem. 58:1993;6565.
29. Waring P., Beaver J. Gen. Pharmac. 27:1996;1311. and references cited therein.
30. Reviewed in Vallee B.L., Auld D.S. Biochemistry. 29:1990;5647.
31. Young K., Silver L.L., Bramhill D., Cameron P., Eveland S.S., Raetz D.R., Hyland S.A., Anderson M.S. J. Biol. Chem. 270:1995;30384.
32. Jackman J.E., Raetz C.R., Fierke C.A. Biochemistry. 38:1999;1902.
33. Note that similar distances (2.55-2.65 Å) separate the three neighboring oxygen atoms in physcion and the gliotoxins.
34. Due to the heterogenous nature of the 1,3-pyridinium polymers, along with their tendency to aggregate, we did not investigate their mode of inhibition of MCA. For recent insights into aggregation related to non-specific or 'promiscuous' inhibitors, see McGovern S.L., Caselli E., Grigorieff N., Shoichet B.K. J. Med. Chem. 45:2002;1712.